In a small cohort of 40 patients with advanced PCA and radioligand therapy, Seifert and colleagues reported that semiautomatically quantified pre-treatment tumor volume (PSMATV50) was significantly associated with OS and independent from other important prognostic factors like alkaline phosphatase (ALP) and PSA [33]. This evidence concerns the gene KLK3 and posterior cortical atrophy.